REGENXBIO Inc. (RGNX): Cost of Revenue
$33.57M
Year ended 2024-12-31
-13.5%
3-year compound annual growth
+32.4%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $33.57M | -9.8% | 2025-03-13, From 2024-01-01 |
| 2023-12-31 | $37.21M | -31.8% | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | $54.55M | +5.2% | 2025-03-13, From 2022-01-01 |
| 2021-12-31 | $51.83M | +45.1% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $35.71M | +333.4% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $8.24M | -14.5% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $9.64M | +464.1% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $1.71M | n/a | 2020-02-26, From 2017-01-01 |